Schistosome immunology: more questions than answers (Q40279125)

19 September 2017

Schistosome immunology: more questions than answers (English)

1 reference

19 September 2017

1 reference

3

1 reference

19 September 2017

Hagan P

1

1 reference

PubMed ID

17040831

19 September 2017

Ndhlovu PD

series ordinal

2

1 reference

19 September 2017

1 October 1998

1 reference

19 September 2017

Trends in Parasitology

1 reference

19 September 2017

14

1 reference

19 September 2017

407-412

1 reference

19 September 2017

10

1 reference

Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses.

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Resistance to reinfection after treatment of urinary schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

In-vitro antibody-dependent killing of schistosomula of Schistosoma haematobium by human eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31–q33

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

The epidemiology and consequences of Schistosoma mansoni infection in West Nile, Uganda. I. Field studies of a community at Panyagoro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Human immunity to Schistosomes: some questions.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Acquired immunity and epidemiology of Schistosoma haematobium.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

On the use of age-intensity data to detect immunity to parasitic infections, with special reference to Schistosoma mansoni in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Puberty and Age-related Changes in Susceptibility to Schistosome Infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Efficacy of praziquantel against Schistosoma mansoni in northern Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Why don't we have a schistosomiasis vaccine?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Schistosomiasis vaccine:research to development

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Dynamics of Schistosoma haematobium infection in a Gambian community. I. The pattern of human infection in the study area

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Dynamics of Schistosoma haematobium infection in a Gambian community. III. Acquisition and loss of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Immunity in human schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Water contact observations in Kenyan communities endemic for schistosomiasis: methodology and patterns of behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Human resistance to Schistosoma infections: age or experience?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Immunoepidemiology of human schistosomes: taking the theory into the field.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

The development of schistosomiasis mansoni in an immunologically naive immigrant population in Masongaleni, Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Herd immunity to filarial infection is a function of vector biting rate.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Antibody-dependent cell-mediated damage to schistosomula in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Eosinophils as mediators of antibody-dependent damage to schistosomula

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Immunity to Schistosoma mansoni in vivo: contradiction or clarification?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Th1-Th2: reliable paradigm or dangerous dogma?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Leaky livers, portal shunting and immunity to schistosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Anti-schistosome IgG4 and IgE at 2 years after chemotherapy: infected versus uninfected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

IgG4 and IgE responses to Schistosoma mansoni adult worms after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Age-dependent reduction of schistosome fecundity in Schistosoma haematobium but not Schistosoma mansoni infections in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

Human schistosomiasis: potential consequences of vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

The significance of proteinuria and haematuria in Schistosoma haematobium infection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901325-8

7 January 2021

10.1016/S0169-4758(98)01325-8

Identifiers

DOI

1 reference

19 September 2017

1 reference

PubMed ID

17040831